{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:30:07Z","timestamp":1761503407842,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.yebeh.2017.10.039","type":"journal-article","created":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T00:32:29Z","timestamp":1511483549000},"page":"68-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Influence of valproate on language functions in children with epilepsy"],"prefix":"10.1016","volume":"78","author":[{"given":"Jin Woong","family":"Doo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soon Chul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.yebeh.2017.10.039_bb0005","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1474-4422(04)00906-8","article-title":"Chronic epilepsy and cognition","volume":"3","author":"Elger","year":"2004","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1016\/j.yebeh.2017.10.039_bb0010","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1469-8749.2002.tb00325.x","article-title":"High incidence of language disorder in children with focal epilepsies","volume":"44","author":"Parkinson","year":"2002","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"10.1016\/j.yebeh.2017.10.039_bb0015","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1469-5812.2005.00134.x-i1","article-title":"The Landau-Kleffner Syndrome","volume":"1","author":"Pearl","year":"2001","journal-title":"Epilepsy Curr"},{"issue":"6","key":"10.1016\/j.yebeh.2017.10.039_bb0020","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1600-0404.1990.tb01008.x","article-title":"Cognitive effects of long-term treatment with phenobarbital and valproic acid in school children","volume":"81","author":"Calandre","year":"1990","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"10.1016\/j.yebeh.2017.10.039_bb0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.yebeh.2005.09.001","article-title":"Neurocognitive effects of phenobarbital discontinuation in epileptic children","volume":"8","author":"Tonekaboni","year":"2006","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.yebeh.2017.10.039_bb0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1542\/peds.80.2.165","article-title":"Psychologic and behavioral effects of antiepileptic drugs in children: a double-blind comparison between phenobarbital and valproic acid","volume":"80","author":"Vining","year":"1987","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.yebeh.2017.10.039_bb0035","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.pediatrneurol.2014.05.033","article-title":"Effects of topiramate on language functions in newly diagnosed pediatric epileptic patients","volume":"51","author":"Kim","year":"2014","journal-title":"Pediatr Neurol"},{"issue":"3","key":"10.1016\/j.yebeh.2017.10.039_bb0040","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.yebeh.2005.07.001","article-title":"Acoustic effects of carbamazepine in benign rolandic epilepsy","volume":"7","author":"Park","year":"2005","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.yebeh.2017.10.039_bb0045","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0920-1211(90)90018-Q","article-title":"Cognitive function in adult epileptic patients established on anticonvulsant monotherapy","volume":"7","author":"Gillham","year":"1990","journal-title":"Epilepsy Res"},{"issue":"2","key":"10.1016\/j.yebeh.2017.10.039_bb0055","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3988\/jcn.2006.2.2.126","article-title":"Cognitive effects of low-dose topiramate compared with oxcarbazepine in epilepsy patients","volume":"2","author":"Kim","year":"2006","journal-title":"J Clin Neurol Seoul Korea"},{"issue":"4","key":"10.1016\/j.yebeh.2017.10.039_bb0060","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.yebeh.2006.03.006","article-title":"Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: a 1-year follow-up","volume":"8","author":"Lee","year":"2006","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2017.10.039_bb0065","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2147\/NDT.S5903","article-title":"Neuropsychological effects of antiepileptic drugs (carbamazepine versus valproate) in adult males with epilepsy","volume":"5","author":"Shehata","year":"2009","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"3","key":"10.1016\/j.yebeh.2017.10.039_bb0070","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3988\/jcn.2008.4.3.99","article-title":"Cognitive effects of antiepileptic drugs","volume":"4","author":"Park","year":"2008","journal-title":"J Clin Neurol Seoul Korea"},{"issue":"2","key":"10.1016\/j.yebeh.2017.10.039_bb0075","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2174\/157015909788848857","article-title":"Minimizing AED adverse effects: improving quality of life in the interictal state in epilepsy care","volume":"7","author":"St. Louis","year":"2009","journal-title":"Curr Neuropharmacol"},{"issue":"4","key":"10.1016\/j.yebeh.2017.10.039_bb0080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/2042098611411127","article-title":"New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?","volume":"2","author":"French","year":"2011","journal-title":"Ther Adv Drug Saf"},{"issue":"10","key":"10.1016\/j.yebeh.2017.10.039_bb0085","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate: a review after 35years of clinical use for the treatment of epilepsy","volume":"16","author":"L\u00f6scher","year":"2002","journal-title":"CNS Drugs"},{"issue":"16","key":"10.1016\/j.yebeh.2017.10.039_bb0090","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1007\/s00018-007-7079-x","article-title":"The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?","volume":"64","author":"Rosenberg","year":"2007","journal-title":"Cell Mol Life Sci"},{"author":"pmhdev","key":"10.1016\/j.yebeh.2017.10.039_bb0095"},{"issue":"1","key":"10.1016\/j.yebeh.2017.10.039_bb0100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2165\/00002018-199005010-00006","article-title":"Acute valproic acid overdose. Clinical course and pharmacokinetic disposition of valproic acid and metabolites","volume":"5","author":"Dupuis","year":"1990","journal-title":"Drug Saf"},{"issue":"2","key":"10.1016\/j.yebeh.2017.10.039_bb0105","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.46.2.465","article-title":"Valproic acid hepatic fatalities. III. U.S. experience since 1986","volume":"46","author":"Bryant","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2017.10.039_bb0110","first-page":"64","article-title":"Acute valproate intoxication: biochemical investigations and hemodialysis treatment","volume":"21","author":"Mortensen","year":"1983","journal-title":"Int J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.yebeh.2017.10.039_bb0115","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.seizure.2007.05.006","article-title":"The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures","volume":"16","author":"Donati","year":"2007","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.yebeh.2017.10.039_bb0120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpsycho.2008.02.003","article-title":"Attention changes in epilepsy patients following 3-month topiramate or valproate treatment revealed by event-related potential","volume":"68","author":"Sun","year":"2008","journal-title":"Int J Psychophysiol"},{"issue":"18","key":"10.1016\/j.yebeh.2017.10.039_bb0125","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1212\/WNL.0b013e3182a9f3ca","article-title":"Pretreatment cognitive deficits and treatment effects on attention in childhood absence epilepsy","volume":"81","author":"Masur","year":"2013","journal-title":"Neurology"},{"year":"2005","series-title":"Test of problem solving","author":"Bae","key":"10.1016\/j.yebeh.2017.10.039_bb0130"},{"issue":"3","key":"10.1016\/j.yebeh.2017.10.039_bb0135","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.bandl.2004.07.001","article-title":"Language in benign childhood epilepsy with centro-temporal spikes abbreviated form: rolandic epilepsy and language","volume":"92","author":"Monjauze","year":"2005","journal-title":"Brain Lang"},{"issue":"5","key":"10.1016\/j.yebeh.2017.10.039_bb0140","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1055\/s-2007-973569","article-title":"Language dysfunction in children with rolandic epilepsy","volume":"29","author":"Staden","year":"1998","journal-title":"Neuropediatrics"},{"issue":"9251","key":"10.1016\/j.yebeh.2017.10.039_bb0145","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(00)03600-X","article-title":"Neuropsychological effects of epilepsy and antiepileptic drugs","volume":"357","author":"Kwan","year":"2001","journal-title":"Lancet Lond Engl"},{"issue":"3","key":"10.1016\/j.yebeh.2017.10.039_bb0150","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/ene.13232","article-title":"A comprehensive assessment of cognitive function in the common genetic generalized epilepsy syndromes","volume":"24","author":"Loughman","year":"2017","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.yebeh.2017.10.039_bb0155","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.yebeh.2016.07.010","article-title":"Epilepsy beyond seizures: predicting enduring cognitive dysfunction in genetic generalized epilepsied","volume":"62","author":"Loughman","year":"2016","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.yebeh.2017.10.039_bb0160","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/01.wnl.0000232737.72555.06","article-title":"Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy","volume":"67","author":"Blum","year":"2006","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.yebeh.2017.10.039_bb0165","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1212\/01.WNL.0000063308.22506.19","article-title":"Differential cognitive and behavioral effects of topiramate and valproate","volume":"60","author":"Meador","year":"2003","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.yebeh.2017.10.039_bb0170","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1111\/j.1528-1167.2009.02199.x","article-title":"Language in pediatric epilepsy","volume":"50","author":"Caplan","year":"2009","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2017.10.039_bb0175","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/brln.1997.1791","article-title":"A theory of neurolinguistic development","volume":"58","author":"Locke","year":"1997","journal-title":"Brain Lang"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505017306649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505017306649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:27:28Z","timestamp":1761503248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505017306649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":34,"alternative-id":["S1525505017306649"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2017.10.039","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of valproate on language functions in children with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2017.10.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}